Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rachel Willen"'
Autor:
WonHee Kim, Liang Ma, Selene Lomoio, Rachel Willen, Sylvia Lombardo, Jinghui Dong, Philip G. Haydon, Giuseppina Tesco
Publikováno v:
Molecular Neurodegeneration, Vol 13, Iss 1, Pp 1-22 (2018)
Abstract Background β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in the production of amyloid beta (Aβ), the toxic peptide that accumulates in the brains of Alzheimer’s disease (AD) patients. Our previous
Externí odkaz:
https://doaj.org/article/7258624d78f2453a9df25d037112256f
Autor:
WonHee Kim, Selene Lomoio, Edward K. Robinson, Giuseppina Tesco, Matthew E. Kennedy, Kevin Z. Ho, Rudolph E. Tanzi, Rachel Willen, Dmitry Prokopenko
Publikováno v:
Sci Transl Med
Axonal dystrophy, indicative of perturbed axonal transport, occurs early during Alzheimer’s disease (AD) pathogenesis. Little is known about the mechanisms underlying this initial sign of the pathology. This study proves that Golgi-localized γ-ear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d52c53f890587c8ff4a5f7839cbee36
https://europepmc.org/articles/PMC8612295/
https://europepmc.org/articles/PMC8612295/
Autor:
Selene Lomoio, Sylvia Lombardo, WonHee Kim, Jinghui Dong, Giuseppina Tesco, Rachel Willen, Liang Ma, Philip G. Haydon
Publikováno v:
Molecular Neurodegeneration
Molecular Neurodegeneration, Vol 13, Iss 1, Pp 1-22 (2018)
Molecular Neurodegeneration, Vol 13, Iss 1, Pp 1-22 (2018)
Background β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in the production of amyloid beta (Aβ), the toxic peptide that accumulates in the brains of Alzheimer’s disease (AD) patients. Our previous studies